FindTrial
Sign In

Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22

Combined Buprenorphine and Behavioral Treatment Without Contingent Reinforcement

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000240
Enrollment
0
Registered
1999-09-21
Start date
1999-04-30
Completion date
Unknown
Last updated
2015-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders, Opioid-Related Disorders

Brief summary

The purpose of this study is to test combined buprenorphine and behavioral treatment with and without contingent reinforcement on opioid and cocaine abstinence.

Interventions

DRUGBuprenorphine

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of Vermont
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
23 Years to 47 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Drug use—
Retention—
Weeks abstinent—
Weeks continuous abstinence—
Overall treatment outcome—
Opioid dependence and psychiatric status—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026